News | December 22, 2024
Briefs: Laurus Bio and Cupid
Laurus Labs informs that Eight Roads Ventures and F-Prime Capital (Investors) have together invested Rs. 120 crores in Laurus Bio
Laurus Labs informs that Eight Roads Ventures and F-Prime Capital (Investors) have together invested Rs. 120 crores in Laurus Bio
Net Profit was at Rs. 10.04 crore, as compared to Rs. 5.12 crore in Q2 FY24, clocking a growth of 96.22%
Innovative product offerings to capitalise on emerging opportunities within and beyond the sexual wellness market
This strategic move aims to make Cupid's high-quality products more accessible to consumers nationwide
The integration of SAP S/4HANA Cloud will equip Cupid Limited with a comprehensive suite of integrated applications,
This significant achievement includes an initial order from GCPL valued at a substantial Rs. 2.4 crore
Total value of the supplies of FC will be US$ 2.773 million
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Cupid Limited has received a purchase order from United Nations Population Fund
Subscribe To Our Newsletter & Stay Updated
